Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

Bente Glintborg; Daniela Di Giuseppe; Johan K. Wallman; Sella A. Provan; Dan Nordstrom; Anna-Mari Hokkanen; Jenny Österlund; Eirik Kristianslund; Tore K. Kvien; Bjorn Gudbjornsson; Merete Lund Hetland; Brigitte Michelsen; Lennart Jacobsson; Johan Askling; Ulf Lindström

doi:10.1093/rheumatology/keac358

Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

Bente Glintborg, Daniela Di Giuseppe, Johan K. Wallman, Sella A. Provan, Dan Nordstrom, Anna-Mari Hokkanen, Jenny Österlund, Eirik Kristianslund, Tore K. Kvien, Bjorn Gudbjornsson, Merete Lund Hetland, Brigitte Michelsen, Lennart Jacobsson, Johan Askling, Ulf Lindström

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Rheumatology
Volym	62
Nummer	2
Sidor (från-till)	647–658
Antal sidor	12
ISSN	1462-0324
DOI	https://doi.org/10.1093/rheumatology/keac358
Status	Publicerad - 1 feb. 2023
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3121 Allmänmedicin, inre medicin och annan klinisk medicin

Åtkomst av dokument

10.1093/rheumatology/keac358

keac358Slutlig publicerad version, 815 KBLicens: CC BY-NC

Citera det här

Glintborg, B., Di Giuseppe, D., Wallman, J. K., Provan, S. A., Nordstrom, D., Hokkanen, A-M., Österlund, J., Kristianslund, E., Kvien, T. K., Gudbjornsson, B., Hetland, M. L., Michelsen, B., Jacobsson, L., Askling, J., & Lindström, U. (2023). Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries. Rheumatology, 62(2), 647–658. https://doi.org/10.1093/rheumatology/keac358

@article{2d0ed22d2e7941209af6c8338cde76bd,

title = "Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries",

keywords = "3121 General medicine, internal medicine and other clinical medicine, DMARDs, Biologic therapies, Epidemiology, Immunosuppressants, Spondylarthropathies",

author = "Bente Glintborg and {Di Giuseppe}, Daniela and Wallman, {Johan K.} and Provan, {Sella A.} and Dan Nordstrom and Anna-Mari Hokkanen and Jenny {\"O}sterlund and Eirik Kristianslund and Kvien, {Tore K.} and Bjorn Gudbjornsson and Hetland, {Merete Lund} and Brigitte Michelsen and Lennart Jacobsson and Johan Askling and Ulf Lindstr{\"o}m",

year = "2023",

month = feb,

day = "1",

doi = "10.1093/rheumatology/keac358",

language = "English",

volume = "62",

pages = "647–658",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "2",

}

Glintborg, B, Di Giuseppe, D, Wallman, JK, Provan, SA, Nordstrom, D, Hokkanen, A-M, Österlund, J, Kristianslund, E, Kvien, TK, Gudbjornsson, B, Hetland, ML, Michelsen, B, Jacobsson, L, Askling, J & Lindström, U 2023, 'Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries', Rheumatology, vol. 62, nr. 2, s. 647–658. https://doi.org/10.1093/rheumatology/keac358

TY - JOUR

T1 - Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

AU - Glintborg, Bente

AU - Di Giuseppe, Daniela

AU - Wallman, Johan K.

AU - Provan, Sella A.

AU - Nordstrom, Dan

AU - Hokkanen, Anna-Mari

AU - Österlund, Jenny

AU - Kristianslund, Eirik

AU - Kvien, Tore K.

AU - Gudbjornsson, Bjorn

AU - Hetland, Merete Lund

AU - Michelsen, Brigitte

AU - Jacobsson, Lennart

AU - Askling, Johan

AU - Lindström, Ulf

PY - 2023/2/1

Y1 - 2023/2/1

KW - 3121 General medicine, internal medicine and other clinical medicine

KW - DMARDs

KW - Biologic therapies

KW - Epidemiology

KW - Immunosuppressants

KW - Spondylarthropathies

U2 - 10.1093/rheumatology/keac358

DO - 10.1093/rheumatology/keac358

M3 - Article

VL - 62

SP - 647

EP - 658

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 2

ER -